154 related articles for article (PubMed ID: 321001)
1. Selective inhibition by danazol of follicle stimulating hormone during the luteal phase.
Lieberman BA; Thom S; Murray MA; Jacobs HS
Br J Obstet Gynaecol; 1977 Jan; 84(1):55-7. PubMed ID: 321001
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Danazol as a contraceptive agent.
Wentz AC; Jones GS; Sapp KC
Contraception; 1976 May; 13(5):619-30. PubMed ID: 1261264
[TBL] [Abstract][Full Text] [Related]
3. Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle.
Fraser IS; Markham R; Robinson M; Thorburn GD
Fertil Steril; 1982 Apr; 37(4):489-93. PubMed ID: 6802677
[TBL] [Abstract][Full Text] [Related]
4. Endocrine effects of danazol in menstruating women.
Guillebaud J; Fraser IS; Thorburn GD; Jenken G
J Int Med Res; 1977; 5 Suppl 3():57-66. PubMed ID: 913882
[No Abstract] [Full Text] [Related]
5. Progestational activity of danazol in the human female subject.
Wentz AC; Jones GS; Sapp KC; King TM
Am J Obstet Gynecol; 1976 Oct; 126(3):378-84. PubMed ID: 961786
[TBL] [Abstract][Full Text] [Related]
6. LHRH and steroid levels in normal ovulatory women.
Stone SC; Dickey RP; Kastin AJ; Schally AV
Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572
[TBL] [Abstract][Full Text] [Related]
7. Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women.
Lemay A; Labrie F; Ferland L; Raynaud JP
Fertil Steril; 1979 Jan; 31(1):29-34. PubMed ID: 369890
[TBL] [Abstract][Full Text] [Related]
8. The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle.
Braun P; Wildt L; Leyendecker G
Fertil Steril; 1983 Jul; 40(1):37-44. PubMed ID: 6345207
[TBL] [Abstract][Full Text] [Related]
9. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women.
Rannevik G; Thorell JI
Acta Obstet Gynecol Scand Suppl; 1984; 123():89-94. PubMed ID: 6437127
[TBL] [Abstract][Full Text] [Related]
10. LHRH analogues can be luteotrophic.
Fleming R; Coutts JR
Clin Endocrinol (Oxf); 1982 Dec; 17(6):593-9. PubMed ID: 6819902
[TBL] [Abstract][Full Text] [Related]
11. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor.
Casper RF; Yen SS
Science; 1979 Jul; 205(4404):408-10. PubMed ID: 377491
[TBL] [Abstract][Full Text] [Related]
12. Effects of danazol on gonadotropin secretion after ovariectomy in rats.
Vilchez-Martinez JA; Pedroza E; Arimura A; Schally AV
Contraception; 1978 Mar; 17(3):283-90. PubMed ID: 348402
[No Abstract] [Full Text] [Related]
13. [A radioimmunoassay of progesterone. Serum progesterone concentrations after synthetic LH-releasing hormone (LH-RH) administrations].
Furuhasi N; OOasi L; Nakagawa K; Hirano M
Nihon Funin Gakkai Zasshi; 1975 Jan; 20(1):41-6. PubMed ID: 1095436
[No Abstract] [Full Text] [Related]
14. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
15. Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women.
Dmowski WP; Headley S; Radwanska E
Fertil Steril; 1983 Jan; 39(1):49-55. PubMed ID: 6401252
[TBL] [Abstract][Full Text] [Related]
16. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
17. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women.
Koyama T; Ohkura T; Kumasaka T; Saito M
Fertil Steril; 1978 Nov; 30(5):549-52. PubMed ID: 363461
[TBL] [Abstract][Full Text] [Related]
18. Danazol: endocrine consequences in healthy women.
Luciano AA; Hauser KS; Chapler FK; Sherman BM
Am J Obstet Gynecol; 1981 Nov; 141(6):723-7. PubMed ID: 6797301
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of induction of luteal phase defects by danazol.
Asch RH; Fernandez EO; Siler-Khodr TM; Bartke A; Pauerstein CJ
Am J Obstet Gynecol; 1980 Apr; 136(7):932-40. PubMed ID: 6767405
[TBL] [Abstract][Full Text] [Related]
20. Danazol has progestin-like actions on the human endometrium.
Kokko E; Jänne O; Kauppila A; Rönnberg L; Vihko R
Acta Endocrinol (Copenh); 1982 Apr; 99(4):588-93. PubMed ID: 6461996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
